This document discusses guidelines for pan-Canadian newborn screening. It defines screening as applying tests to asymptomatic populations to identify those who need further investigation or treatment for better outcomes. Diagnosis involves evaluating symptomatic patients to confirm or rule out disease. The document outlines elements of an effective screening system, including education, testing, follow-up, data management, and governance. It discusses the use of dried blood spot samples, and notes work by a federal-provincial-territorial group to establish consensus on minimum screening panels and policies around sample storage and secondary use.